334 related articles for article (PubMed ID: 31295363)
1. Higher dietary protein intake preserves lean body mass, lowers liver lipid deposition, and maintains metabolic control in participants with long-chain fatty acid oxidation disorders.
Gillingham MB; Elizondo G; Behrend A; Matern D; Schoeller DA; Harding CO; Purnell JQ
J Inherit Metab Dis; 2019 Sep; 42(5):857-869. PubMed ID: 31295363
[TBL] [Abstract][Full Text] [Related]
2. Resting and total energy expenditure of patients with long-chain fatty acid oxidation disorders (LC-FAODs).
DeLany JP; Horgan A; Gregor A; Vockley J; Harding CO; Gillingham MB
Mol Genet Metab; 2023 Mar; 138(3):107519. PubMed ID: 36696737
[TBL] [Abstract][Full Text] [Related]
3. Triheptanoin versus trioctanoin for long-chain fatty acid oxidation disorders: a double blinded, randomized controlled trial.
Gillingham MB; Heitner SB; Martin J; Rose S; Goldstein A; El-Gharbawy AH; Deward S; Lasarev MR; Pollaro J; DeLany JP; Burchill LJ; Goodpaster B; Shoemaker J; Matern D; Harding CO; Vockley J
J Inherit Metab Dis; 2017 Nov; 40(6):831-843. PubMed ID: 28871440
[TBL] [Abstract][Full Text] [Related]
4. Postprandial de novo lipogenesis and metabolic changes induced by a high-carbohydrate, low-fat meal in lean and overweight men.
Marques-Lopes I; Ansorena D; Astiasaran I; Forga L; Martínez JA
Am J Clin Nutr; 2001 Feb; 73(2):253-61. PubMed ID: 11157321
[TBL] [Abstract][Full Text] [Related]
5. Long-term major clinical outcomes in patients with long chain fatty acid oxidation disorders before and after transition to triheptanoin treatment--A retrospective chart review.
Vockley J; Marsden D; McCracken E; DeWard S; Barone A; Hsu K; Kakkis E
Mol Genet Metab; 2015; 116(1-2):53-60. PubMed ID: 26116311
[TBL] [Abstract][Full Text] [Related]
6. Basal and postprandial substrate oxidation rates in obese women receiving two test meals with different protein content.
Labayen I; Díez N; Parra D; González A; Martínez JA
Clin Nutr; 2004 Aug; 23(4):571-8. PubMed ID: 15297093
[TBL] [Abstract][Full Text] [Related]
7. Circulating FGF21 in humans is potently induced by short term overfeeding of carbohydrates.
Lundsgaard AM; Fritzen AM; Sjøberg KA; Myrmel LS; Madsen L; Wojtaszewski JFP; Richter EA; Kiens B
Mol Metab; 2017 Jan; 6(1):22-29. PubMed ID: 28123934
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Energy Expenditure and Oxidation of Energy Substrates in Adult Males after Intake of Meals with Varying Fat and Carbohydrate Content.
Adamska-Patruno E; Ostrowska L; Golonko A; Pietraszewska B; Goscik J; Kretowski A; Gorska M
Nutrients; 2018 May; 10(5):. PubMed ID: 29772667
[TBL] [Abstract][Full Text] [Related]
9. A PUFA-rich diet improves fat oxidation following saturated fat-rich meal.
Stevenson JL; Miller MK; Skillman HE; Paton CM; Cooper JA
Eur J Nutr; 2017 Aug; 56(5):1845-1857. PubMed ID: 27193583
[TBL] [Abstract][Full Text] [Related]
10. Altered body composition and energy expenditure but normal glucose tolerance among humans with a long-chain fatty acid oxidation disorder.
Gillingham MB; Harding CO; Schoeller DA; Matern D; Purnell JQ
Am J Physiol Endocrinol Metab; 2013 Nov; 305(10):E1299-308. PubMed ID: 24064340
[TBL] [Abstract][Full Text] [Related]
11. [The role of oils containing triacylglycerols and medium-chain fatty acids in the dietary treatment of obesity. The effect on resting energy expenditure and serum lipids].
Hainer V; Kunesová M; Stich V; Zák A; Parizková J
Cas Lek Cesk; 1994 Jun; 133(12):373-5. PubMed ID: 8069895
[TBL] [Abstract][Full Text] [Related]
12. Modifying the Dietary Carbohydrate-to-Protein Ratio Alters the Postprandial Macronutrient Oxidation Pattern in Liver of AMPK-Deficient Mice.
Chalvon-Demersay T; Even PC; Chaumontet C; Piedcoq J; Viollet B; Gaudichon C; Tomé D; Foretz M; Azzout-Marniche D
J Nutr; 2017 Sep; 147(9):1669-1676. PubMed ID: 28747486
[No Abstract] [Full Text] [Related]
13. Dietary supplementation of very long-chain n-3 fatty acids decreases whole body lipid utilization in the rat.
Rustan AC; Hustvedt BE; Drevon CA
J Lipid Res; 1993 Aug; 34(8):1299-309. PubMed ID: 8409764
[TBL] [Abstract][Full Text] [Related]
14. UX007 for the treatment of long chain-fatty acid oxidation disorders: Safety and efficacy in children and adults following 24weeks of treatment.
Vockley J; Burton B; Berry GT; Longo N; Phillips J; Sanchez-Valle A; Tanpaiboon P; Grunewald S; Murphy E; Humphrey R; Mayhew J; Bowden A; Zhang L; Cataldo J; Marsden DL; Kakkis E
Mol Genet Metab; 2017 Apr; 120(4):370-377. PubMed ID: 28189603
[TBL] [Abstract][Full Text] [Related]
15. Short-term alterations in carbohydrate energy intake in humans. Striking effects on hepatic glucose production, de novo lipogenesis, lipolysis, and whole-body fuel selection.
Schwarz JM; Neese RA; Turner S; Dare D; Hellerstein MK
J Clin Invest; 1995 Dec; 96(6):2735-43. PubMed ID: 8675642
[TBL] [Abstract][Full Text] [Related]
16. The ability of genetically lean or fat slow-growing chickens to synthesize and store lipids is not altered by the dietary energy source.
Baéza E; Gondret F; Chartrin P; Le Bihan-Duval E; Berri C; Gabriel I; Narcy A; Lessire M; Métayer-Coustard S; Collin A; Jégou M; Lagarrigue S; Duclos MJ
Animal; 2015 Oct; 9(10):1643-52. PubMed ID: 25959107
[TBL] [Abstract][Full Text] [Related]
17. Anaplerotic treatment of long-chain fat oxidation disorders with triheptanoin: Review of 15 years Experience.
Roe CR; Brunengraber H
Mol Genet Metab; 2015 Dec; 116(4):260-8. PubMed ID: 26547562
[TBL] [Abstract][Full Text] [Related]
18. Normal vs. high-protein weight loss diets in men: effects on body composition and indices of metabolic syndrome.
Tang M; Armstrong CL; Leidy HJ; Campbell WW
Obesity (Silver Spring); 2013 Mar; 21(3):E204-10. PubMed ID: 23592676
[TBL] [Abstract][Full Text] [Related]
19. The Pharmacokinetics of Triheptanoin and Its Metabolites in Healthy Subjects and Patients With Long-Chain Fatty Acid Oxidation Disorders.
Lee SK; Gupta M; Shi J; McKeever K
Clin Pharmacol Drug Dev; 2021 Nov; 10(11):1325-1334. PubMed ID: 33789001
[TBL] [Abstract][Full Text] [Related]
20. Long-chain fatty acid oxidation disorders and current management strategies.
Vockley J
Am J Manag Care; 2020 Aug; 26(7 Suppl):S147-S154. PubMed ID: 32840329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
